DMAA "Responds" to Business Week Article Slamming Disease Management

The response was weak but did make a good point. The best example they could cite was a program that lowered co-payments to encourage better medication adherence. This was not the standard DM referred to in the article. But it does emphasize that low cost interventions to increase compliance can have a very favorable return on investment.